Ji Hong Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ji Hong Kim has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Jong Pil Park
Department of Food Science and Technology, and GreenTech-based Food Safety Research Group, BK21 Four, Chung-Ang University, Anseong, 17546, Republic of Korea
6 shared publications Tae Jung Park
Department of Chemistry, Institute of Interdisciplinary Convergence Research, Research Institute of Chem-Bio Diagnostic Technology, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul 06974, Republic of Korea
5 shared publications- Chae Hwan Cho
Basic Research Laboratory, Department of Food Science and Technology, Chung-Ang University, Anseong, 17546, Republic of Korea
4 shared publications - Chang-Hyung Choi
School of Chemical Engineering, Yeungnam University, Gyeongsan, Republic of Korea
3 shared publications Jae Hwan Shin
Department of Food Science and Technology, Chung-Ang University, Anseong, 17546, Republic of Korea
3 shared publicationsChae Hwan Cho
Department of Food Science and Technology, Chung-Ang University, Anseong, 17546, Republic of Korea
2 shared publications
Latest Publications
- 9 January 2026
- Published by Springer Nature in Nature Protocols
- Vol. 21 (7) , 3068-3097
Deployment of a cloud-based passive defecation monitoring system for continuous gut health monitoring
With the growing demand for accurate yet effortless health monitoring at home, most current approaches to stool analysis rely on self-reported diaries that are prone to recall bias and low adherence. Here we present a fully passive alternative: the Precision Health Integrated Diagnostic (PHIND) system, a smart-toilet-based platform that enables automated defecation monitoring without requiring users to alter their daily routines. By integrating optical and pressure sensors with cloud-based convolutional neural networks, the PHIND system classifies stool form according to the Bristol Stool Form Scale and records key defecatory parameters, including total event time, defecation duration and time to first stool drop. The protocol proceeds in three principal stages: (1) assembling and mounting the hardware onto a conventional toilet; (2) training convolutional neural network models for stool classification and event detection; and (3) image acquisition and deploying cloud infrastructure for real-time analysis, data storage and visualization. Compared with traditional methods that depend on user-reported stool diaries, PHIND provides objective, near real-time data free from recall error, enabling more reliable early detection and long-term management of gastrointestinal conditions. Researchers and clinicians can expect high classification accuracy and robust, longitudinal insights into defecation patterns. The complete protocol—from hardware setup to system validation—can typically be completed within 2 d, excluding printed circuit board manufacturing, which generally requires up to 15 d depending on the manufacturing provider.
- 9 January 2026
- Published by Springer Nature in Nature Protocols
- Vol. 21 (7) , 3068-3097
Deployment of a cloud-based passive defecation monitoring system for continuous gut health monitoring
With the growing demand for accurate yet effortless health monitoring at home, most current approaches to stool analysis rely on self-reported diaries that are prone to recall bias and low adherence. Here we present a fully passive alternative: the Precision Health Integrated Diagnostic (PHIND) system, a smart-toilet-based platform that enables automated defecation monitoring without requiring users to alter their daily routines. By integrating optical and pressure sensors with cloud-based convolutional neural networks, the PHIND system classifies stool form according to the Bristol Stool Form Scale and records key defecatory parameters, including total event time, defecation duration and time to first stool drop. The protocol proceeds in three principal stages: (1) assembling and mounting the hardware onto a conventional toilet; (2) training convolutional neural network models for stool classification and event detection; and (3) image acquisition and deploying cloud infrastructure for real-time analysis, data storage and visualization. Compared with traditional methods that depend on user-reported stool diaries, PHIND provides objective, near real-time data free from recall error, enabling more reliable early detection and long-term management of gastrointestinal conditions. Researchers and clinicians can expect high classification accuracy and robust, longitudinal insights into defecation patterns. The complete protocol—from hardware setup to system validation—can typically be completed within 2 d, excluding printed circuit board manufacturing, which generally requires up to 15 d depending on the manufacturing provider.
- 6 September 2024
- Published by Elsevier in Chemosphere
- Vol. 364, 143274
Rapid and sensitive detection of domoic acid in shellfish using a magnetic bead-based competitive ELISA with a high-affinity peptide as a molecular binder
- 6 September 2024
- Published by Elsevier in Chemosphere
- Vol. 364, 143274
Rapid and sensitive detection of domoic acid in shellfish using a magnetic bead-based competitive ELISA with a high-affinity peptide as a molecular binder
- 2 April 2024
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 255, 116269
Nanozyme-assisted molecularly imprinted polymer-based indirect competitive ELISA for the detection of marine biotoxin
- 2 April 2024
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 255, 116269
Nanozyme-assisted molecularly imprinted polymer-based indirect competitive ELISA for the detection of marine biotoxin
- 25 February 2023
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1251, 341018
Highly sensitive and label-free detection of influenza H5N1 viral proteins using affinity peptide and porous BSA/MXene nanocomposite electrode
- 25 February 2023
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1251, 341018
Highly sensitive and label-free detection of influenza H5N1 viral proteins using affinity peptide and porous BSA/MXene nanocomposite electrode
- Open Access
- 13 January 2022
- Published by Elsevier in SSRN Electronic Journal
Performance Improvement Using Gold Nanoparticle-Embedded MXene Based Electrochemical Peptide Sensor for Cathepsin B Detection
Cathepsin B, a cysteine protease, is considered a potential biomarker for early diagnosis of cancer, because of its overexpression and increased level in tumors and extracellular fluids, during cancer invasion and progression. Here, for the first time, identification and characterization of high-affinity peptides, specific to cathepsin B, for developing peptide-based electrochemical biosensors, has been reported. A phage-display library was biopanned against biotinylated cathepsin B, to identify a high-affinity peptide with the sequence WDMWPSMDWKAE. The identified peptide-displaying phage clones and phage-free synthetic peptides were characterized using enzyme-linked immunosorbent assays and electrochemical analysis (square wave voltammetry (SWV) and cyclic voltammetry (CV)). Feasibilities of phage-on-a-sensor, peptide-on-a-sensor, and peptide-on-a-MXene sensor were evaluated. Limit of detection and binding affinity values of the peptide-on-a-MXene sensor were five to eight times lower than those of the two other sensors, indicating better cathepsin B detection applicabilities (good recovery (86-102%) and %RSD (< 11%) with clinical samples, and distinguish different stages of Crohn’s disease). Furthermore, the concentration of cathepsin B measured by our sensor was good correlation with those estimated by the commercially available ELISA. This study could promote development of alternative, antibody-free detection methods for clinical cancer and other disease testing.
- 13 January 2022
- Published by Elsevier in SSRN Electronic Journal
Open AccessPerformance Improvement Using Gold Nanoparticle-Embedded MXene Based Electrochemical Peptide Sensor for Cathepsin B Detection
Cathepsin B, a cysteine protease, is considered a potential biomarker for early diagnosis of cancer, because of its overexpression and increased level in tumors and extracellular fluids, during cancer invasion and progression. Here, for the first time, identification and characterization of high-affinity peptides, specific to cathepsin B, for developing peptide-based electrochemical biosensors, has been reported. A phage-display library was biopanned against biotinylated cathepsin B, to identify a high-affinity peptide with the sequence WDMWPSMDWKAE. The identified peptide-displaying phage clones and phage-free synthetic peptides were characterized using enzyme-linked immunosorbent assays and electrochemical analysis (square wave voltammetry (SWV) and cyclic voltammetry (CV)). Feasibilities of phage-on-a-sensor, peptide-on-a-sensor, and peptide-on-a-MXene sensor were evaluated. Limit of detection and binding affinity values of the peptide-on-a-MXene sensor were five to eight times lower than those of the two other sensors, indicating better cathepsin B detection applicabilities (good recovery (86-102%) and %RSD (< 11%) with clinical samples, and distinguish different stages of Crohn’s disease). Furthermore, the concentration of cathepsin B measured by our sensor was good correlation with those estimated by the commercially available ELISA. This study could promote development of alternative, antibody-free detection methods for clinical cancer and other disease testing.
- 1 September 2021
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 343
Biomimetic isolation of affinity peptides for electrochemical detection of influenza virus antigen
- 1 September 2021
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 343
Biomimetic isolation of affinity peptides for electrochemical detection of influenza virus antigen